Document is current
Any future updates will be listed below
-
Authors
Trentadue, Taylor P.
Thoreson, Andrew
Lopez, Cesar
Breighner, Ryan E.
Leng, Shuai
Kakar, Sanjeev
Rizzo, Marco
Zhao, Kristin D.
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (F31 AR082227)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR071338)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32 AR056950)
National Institute of General Medical Sciences (T32 GM065841)
National Institute of General Medical Sciences (T32 GM145408)
- License Information
-
More Information
Article History
Received: 4 November 2024
Revised: 17 December 2024
Accepted: 29 December 2024
First Online: 5 February 2025
Declarations
:
: This study was approved by the Institutional Review Board at the Mayo Clinic (IRB 20–007668).
: Work was performed at the Mayo Clinic, Rochester, Minnesota.
: The authors acknowledge multiple funding sources. REB holds a consulting contract with Stryker Corporation. SK receives royalties from Arthrex. The authors declare no other known conflicts of interest with respect to the research, authorship, and/or publication of this article.
: All participants provided written informed consent prior to participation.
: During written informed consenting, participants were informed that de-identified results of the research study may be made public (for example, through scientific meetings, reports, or media).
